Immunology News and Research

Latest Immunology News and Research

T-cell responses after COVID-19 and vaccinations

A new study published in the journal Frontiers in immunology examines the cell-mediated immunity in BNT162b2 COVID-19 mRNA vaccinated health care workers and COVID-19 patients.

12 May 2022

Study shows how MS patients treated with Rituximab react to COVID-19 vaccination

MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts.

12 May 2022

Mitochondrial respiratory chain is essential for NLRP3 inflammasome activation

Northwestern Medicine investigators recently discovered that the mitochondrial respiratory chain — a series of protein complexes essential for a cellular respiration and energy production — is necessary for the activation of another protein complex linked to inflammation and the progression of chronic diseases, according to a study published in Nature Immunology.

12 May 2022

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Researchers performed an unbiased evaluation of the early memory B cell repertoire specific for the Omicron and Delta variants of SARS-CoV-2.

12 May 2022

Research reveals how a leaky gut leads to inflammation in the lungs

Why are older adults more likely to get seriously ill or even die from pneumonia? It turns out the cause may have as much to do with the gut as it does with the lungs.

11 May 2022

Predictive marker and potential treatment option for IBD discovered

There is an urgent need for new and better treatments for people who suffer from Inflammatory Bowel Disease (IBD), a group of disorders that includes ulcerative colitis and Crohn's disease.

10 May 2022

Rural California hatches plan for engineered mosquitoes to battle stealthy predator

Bryan Ruiz moved his family into a newly built home in this Central Valley farming center seven months ago and almost immediately found they were under assault.

10 May 2022

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Scientists have focused on determining the cause-effect relationship between SARS-CoV-2 antibody titers and COVID-19 disease severity.

9 May 2022

LJI researchers uncover new drug target for severe asthma, lung fibrosis

If you've ever struggled to breathe, you've had a moment of hypoxia-;a lack of oxygen. Hypoxia can have long-term effects. In fact, doctors describe hypoxia as an "initial insult."

9 May 2022

T cell behavior informs metastatic melanoma outcomes

Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and new research may help explain why.

9 May 2022

COVID-19 pandemic associated with increased anxiety and asthma symptoms in asthma sufferers

In the past two years, COVID-19 has provoked anxiety throughout the world for people worried they and their loved ones would get the virus and suffer tragic consequences.

5 May 2022

Discovery provides critical clues to why many immunotherapies trigger dangerous side effects

It's not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started showing adverse side effects during a cancer immunotherapy trial, researchers at La Jolla Institute for Immunology (LJI) Center for Cancer Immunotherapy and University of Liverpool went back through the data and worked with patient samples to see what went wrong.

5 May 2022

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill them.

4 May 2022

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

Scientists have discussed the possibilities of developing oral replicon-based mRNA vaccines against SARS-CoV-2.

4 May 2022

Researchers reveal the mechanism of action of century-old BCG vaccine

The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, it has surprisingly been found to protect newborns and young infants against multiple bacterial and viral infections unrelated to TB. There's even some evidence that it can reduce severity of COVID-19.

4 May 2022

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

3 May 2022

Researchers discover how Acinetobacter baumannii can survive on hospital surfaces without water

The pathogen Acinetobacter baumannii can survive on hospital surfaces -; without water -; for months, an ability that has helped it become a leading cause of hospital-acquired infections.

2 May 2022

Antibiotics may disrupt microbiome to cause recurrent UTIs

A study by researchers at Washington University School of Medicine in St. Louis and the Broad Institute of MIT and Harvard suggests that women who get recurrent urinary tract infections (UTIs) may be caught in a vicious cycle in which antibiotics given to eradicate one infection predispose them to develop another.

2 May 2022

Poor asthma control triggered by SARS-CoV-2

In a new study, researchers noted that COVID-19 could trigger poor pediatric asthma control.

29 Apr 2022

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

A recent study published in the journal Immunology analyzed whether sex mattered in the immune response to SARS-CoV-2.

29 Apr 2022

Immunology News and Research

Latest Immunology News and Research

T-cell responses after COVID-19 and vaccinations

Study shows how MS patients treated with Rituximab react to COVID-19 vaccination

Mitochondrial respiratory chain is essential for NLRP3 inflammasome activation

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Research reveals how a leaky gut leads to inflammation in the lungs

Predictive marker and potential treatment option for IBD discovered

Rural California hatches plan for engineered mosquitoes to battle stealthy predator

Severe symptoms result in high titers of SARS-CoV-2 antibodies

LJI researchers uncover new drug target for severe asthma, lung fibrosis

T cell behavior informs metastatic melanoma outcomes

COVID-19 pandemic associated with increased anxiety and asthma symptoms in asthma sufferers

Discovery provides critical clues to why many immunotherapies trigger dangerous side effects

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

Researchers reveal the mechanism of action of century-old BCG vaccine

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

Researchers discover how Acinetobacter baumannii can survive on hospital surfaces without water

Antibiotics may disrupt microbiome to cause recurrent UTIs

Poor asthma control triggered by SARS-CoV-2

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration